Exquiron Biotech Company
Exquiron is dedicated to contract research in early stage drug discovery. Exquiron Biotech is dedicated to state-of-the-art hit identification and validation services for its customers. With a combined team track record of over 60 years in early stage drug discovery and a high level of expertise and flexibility, they help their customers advance their programs and generate added value in the areas of pharmaceutical drug discovery and nutraceuticals.
Technology:
Precision Medicine
Industry:
P3 Medicine
Headquarters:
Reinach, Aargau, Switzerland
Founded Date:
2013
Employees Number:
11-50
Funding Status:
M&A
Register and Claim Ownership